Walter Sloboda

Walter Sloboda is a retired psychologist who has served in government in several prevention-related capacities.  His major work has been with the Food and Drug Administration (FDA), the National Institute of Mental Health (NIMH), and the Substance Abuse and Mental Health Services Administration (SAMHSA). He served as a Senior Statistician with FDA introducing updated statistical analytic approaches and consulting this drug industry statisticans.  Also with the FDA, Mr. Sloboda served as a member of the neuropharmacological review team in the Division of Neuropharmacological Drug Products involved with the development of rating instruments used with patients receiving drug therapy and later, as a member of the Scientific Investigations Branch responsible for the monitoring of clinical studies in neurologic, psychopharmacologic, anestheicm and hypnotic drugs both in the United States and internationally.  Among his responsibilities was to liase with regulatory officials in Germany and the United Kingdom.  He also served as Scientific Review Administrator both at NIMH where he established the review process for the  HIV/AIDS research program and at SAMHSA where he oversaw the reviews of an array of financing mechanisms in support of substance use and mental health services. He has received several awards including the NIH Director’s Award for Outstanding Achievement for his HIV/AIDS work and the SAMHSA Administrator’s Award for Meritorious Achievement. He has several pubications primarily on memory but also on the effects of drugs/anesthetics.

Prevention Talks: Providing Family-Based Prevention during COVID-19: Challenges and

Opportunities for Prevention Professionals. December 9, 2020 @ 2 pm ET. Sign up here! 

419.566.3444

© 2020 Copyright by Applied Prevention Science International (APSI)

  • Facebook
  • Twitter